Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

Erythromycin

erythromycin
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Ery-Tab, Erytab DELAYED RELEASE TABLET, ORAL 250 mg, 500 mg      
Ery-Tab, Erytab DELAYED RELEASE TABLET, ORAL 333 mg    
Erythrocin Lactobionate POWDER FOR INJECTION, INJECTABLE lactobionate 500 mg, lactobionate 1 g      
E.E.S.-200 SUSPENSION, ORAL ethylsuccinate 200 mg/5 mL      
E.E.S.-400 SUSPENSION, ORAL ethylsuccinate 400 mg/5 mL      
E.E.S.-400 TABLET, ORAL ethylsuccinate 400 mg      
VIEW MORE Erthromycins
CLASS
08121204
Comments:

Automatic IV to PO conversion per IV to oral conversion guidelines. IV to PO Conversion Guidelines

Erythomycin IV dose standardization: For GI motility use ONLY - interchange doses 100-399 mg to 250 mg AND doses 400-650 mg to 500 mg.

Tachyphylaxis may occur from serval days to weeks after initiation, if it appears not to be adding any clinical benefit, the pharmacist may recommend discontinuation.

ORDERED FORMULATION THERAPEUTIC INTERCHANGE
erythromycin (Ery-Tab)
  • 333 mg oral q 6-8 hours
  eryhtromcyin (Ery-Tab)
  • 250 mg oral q6 hours

Reviewed: March 25, 2014 (erythromycin IV dosing for GI motility), 23 August 2016 (Ery-Tab)

Last updated: Jun. 27, 2017
  • Formulary, Not Routinely Stocked: EES-400 mg Tab






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved